Stay updated on Novel Therapeutics for High-Risk AML Clinical Trial
Sign up to get notified when there's something new on the Novel Therapeutics for High-Risk AML Clinical Trial page.

Latest updates to the Novel Therapeutics for High-Risk AML Clinical Trial page
- CheckyesterdayChange DetectedThe web page has added a facility name and location details, along with a series of study status updates extending into 2025, while removing some location-related terms and specific dates.SummaryDifference100%
- Check8 days agoChange DetectedThe date for an event has been updated from August 14, 2025, to August 20, 2025.SummaryDifference0.3%
- Check15 days agoChange DetectedThe web page has been updated to a new version, v2.16.12, and the previous version, v2.16.11, has been removed. Additionally, a date of 2025-08-14 has been added.SummaryDifference0.6%
- Check22 days agoChange DetectedThe web page has updated its version from v2.16.10 to v2.16.11 and changed the date from 2025-07-30 to 2025-08-06.SummaryDifference1.0%
- Check29 days agoChange DetectedThe web page has removed a service alert regarding planned maintenance and updated the version number from v2.16.8 to v2.16.10. Additionally, a date has been deleted from the page.SummaryDifference4%
- Check37 days agoChange DetectedThe page has been updated to reflect a new revision version (v2.16.8) and a new date (2025-07-20), replacing the previous revision (v2.16.6) and date (2025-07-17).SummaryDifference1%
Stay in the know with updates to Novel Therapeutics for High-Risk AML Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Novel Therapeutics for High-Risk AML Clinical Trial page.